Frontiers in immunology

international review of cell and molecular biology

current rheumatology reports

[1] Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp Risk Allele Drive the Expansion of FOXP3 Regulatory T Cells and PD-1 Expression.

[2] Intracellular RNA Sensing in Mammalian Cells: Role in Stress Response and Cancer Therapies.

[3] Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics.

[4] understanding viral dsrna-mediated innate immune responses at the cellular level using a rainbow trout model

[5] type i interferon induced and antagonized by foot-and-mouth disease virus

[6] h-ras exerts opposing effects on type i interferon responses depending on its activation status

[7] does type i interferon limit protective neutrophil responses during pulmonary francisella tularensis infection?

[8] plasmacytoid dendritic cells in atherosclerosis

[9] transient depletion of cd169+ cells contributes to impaired early protection and effector cd8+ t cell recruitment against mucosal respiratory syncytial virus infection

[10] An easy and reliable strategy for making type I interferon signature analysis comparable among research centers

[11] RIG-I is responsible for activation of type i interferon pathway in Seneca Valley virus-infected porcine cells to suppress viral replication 11 Medical and Health Sciences 1108 Medical Microbiology 11 Medical and Health Sciences 1107 Immunology

[12] Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition.

[13] Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics.

[14] Catching up with important players in atherosclerosis: type I interferons and neutrophils

[15] type i interferon induced and antagonized by foot-and-mouth disease virus

[16] interplay between sars-cov-2 and the type i interferon response.

[17] type i interferon-independent dendritic cell priming and antitumor t cell activation induced by a mycoplasma fermentans lipopeptide

[18] h-ras exerts opposing effects on type i interferon responses depending on its activation status

[19] tank-binding kinase 1 (tbk1) isoforms negatively regulate type i interferon induction by inhibiting tbk1-irf3 interaction and irf3 phosphorylation

[20] type i interferon regulates the expression of long noncoding rnas

[21] does type i interferon limit protective neutrophil responses during pulmonary francisella tularensis infection?

[22] bunyaviruses and the type i interferon system

[23] interplay between janus kinase/signal transducer and activator of transcription signaling activated by type i interferons and viral antagonism

[24] exogenous stimulation of type i interferon protects mice with chronic granulomatous disease from aspergillosis through early recruitment of host-protective neutrophils into the lung